Also on this list

SnagRx
$69 semaglutide and $119 tirzepatide "locked in for life," but every payment is final.
On our semaglutide provider ranking. DrMedHealth is reviewed here but not listed there.
Read the SnagRx review →
Provider review
Its GLP-1 service is gone; the website is now an AI health directory.
In October 2026 its web address shows an "AI Health Assistant" for finding doctors and pharmacies. Its contact page calls the GLP-1 business "our former telehealth service" and sends existing patients to a CareGLP patient portal.
DrMedHealth no longer operates. As of October 2026, its website is an AI health directory, and its contact page calls the GLP-1 business "our former telehealth service," sending existing patients to a CareGLP portal. There is nothing to buy; this review stays up as a record.
Transparency scorecard
1 of 4 disclosed openly
What DrMedHealth discloses about itself, read from its own pages — not estimated.
Pharmacy category stated
Not disclosed
States no federal regulatory category (503A/503B) for its pharmacy on its own site.
State coverage published
Not disclosed
Publishes no state coverage list — availability is something you learn during signup.
A real price is published
Not disclosed
No dollar figure could be found on its own public pages.
No hidden commitment trap
Disclosed
The advertised price is the ongoing price — no prepay or auto-refill required to unlock it.
This review's stake, stated plainly — some of the outbound links on this site are affiliate links; start a program through one and we may earn a commission at no extra cost to you. A commission does not change what a review says. Full disclosure here.
At a glance
Pharmacy
Not categorized
Labs
Not published
States
Not published
Also on this list

SnagRx
$69 semaglutide and $119 tirzepatide "locked in for life," but every payment is final.
On our semaglutide provider ranking. DrMedHealth is reviewed here but not listed there.
Read the SnagRx review →What this price covers
Medication
Not disclosed
Provider visits
Not disclosed
Shipping
Not disclosed
Lab work
Not disclosed
Coaching
Not disclosed
What they advertise
Pricing not published — it no longer sells GLP-1s.
What you actually pay
Pricing not published. Nothing can be bought.
Money you will meet later
DrMedHealth no longer sells compounded GLP-1s. Its website, run by the same company (Public Health Solution LLC, Fredericksburg, VA), is now an AI health directory with no medications, prices or sign-up. Its contact page tells existing patients to manage any active prescription through their CareGLP patient portal or by email. Until at least August 2026 it sold compounded semaglutide from $199 a month and tirzepatide from $299, through unnamed 503A pharmacies. In June 2026, FDA sent it a warning letter (MARCS-CMS 728278) for advertising its compounded drugs as having the "Same active ingredient as Ozempic®" and "Same active ingredient as Mounjaro®," claims FDA found suggest the drugs are FDA-approved or evaluated for safety and effectiveness when they are not.
DrMedHealth is not ranked on any of our boards. This is a standalone read of what the company publishes about itself — the providers we do rank in this category are on our semaglutide provider ranking.
DrMedHealth states no 503A/503B category for the pharmacy that fills your prescription.
Never named while it sold GLP-1s; it said only that its medications were "prepared by licensed 503A U.S. pharmacies."
A 503A pharmacy compounds for one named patient; a 503B outsourcing facility manufactures in batches under CGMP. Neither is a quality guarantee on its own — a named facility is simply a fact you can check, and an unnamed “partner pharmacy network” is not. Compounded peptides are not FDA-approved.
Not published — it no longer sells GLP-1s.
The part they would rather you skipped
There is nothing left to buy. DrMedHealth's site is now an AI health directory, and its contact page calls the GLP-1 business "our former telehealth service." It also carries an FDA warning letter (MARCS-CMS 728278, June 8, 2026) for marketing its compounded drugs as having the "same active ingredient" as Ozempic and Mounjaro.
Other providers on our semaglutide provider ranking. DrMedHealth is reviewed here but not listed there.






183 more providers are on our semaglutide provider ranking — see the full list. Every provider we review →
A provider comparison is half the decision. The other half is whether the compound does anything for you at all. The evidence below is where that gets settled.
Facts on this page reflect DrMedHealth's own public disclosures when we last checked them. Provider names and logos on this page identify the company under review; their use does not imply endorsement, sponsorship or affiliation. This page is informational and not medical advice; compounded peptides are not FDA-approved. See our disclosure and editorial policy.